HEALTHCARE SERVICES GROUP INC(HCSG)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #756 of 2,879 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
HCSG Stock Analysis & AI Quality Score
AI stock analysis and institutional research for HEALTHCARE SERVICES GROUP INC (HCSG), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores HCSG at 62.1/100 on a 32-signal composite quality model, placing it at rank #756 of 2,879 stocks — the top half of the AI-ranked universe. HCSG scores in the top quartile across institutional flow (84.7), earnings quality (78.4), balance sheet strength (77.9). Based on the latest XBRL financial filings (Q1 2026), HEALTHCARE SERVICES GROUP INC reports quarterly revenue of $462.8M, net income of $26.1M, an operating margin of 7.5%. Top institutional holders of HCSG by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. HCSG trades on the Nasdaq exchange and files with the SEC under CIK 731012. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HCSG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HEALTHCARE SERVICES GROUP INC directly from SEC EDGAR. HEALTHCARE SERVICES GROUP INC's 13F Pro composite quality score has ranged between 33 and 62 since 2021, currently 62.1 — an improving long-term trajectory across 28 quarterly and live scoring snapshots.
Revenue
Q1 2026
$462.8M
Net Income
Q1 2026
$26.1M
Free Cash Flow
Q1 2026
$42.3M
Operating Margin
Q1 2026
7.5%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-1.1% YoYNet Income
+12.1% YoYEPS (Diluted)
+13.0% YoYTotal Assets
+9.7% YoYOp. Cash Flow
+632.6% YoY| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Revenue | $1.67B -1.1% | $1.69B +2.9% | $1.64B -6.7% | $1.76B -4.4% | $1.84B -8.1% | $2.00B |
| Net Income | $38.4M +12.1% | $34.2M -29.5% | $48.5M -50.8% | $98.7M +52.8% | $64.6M -22.7% | $83.5M |
| EPS (Diluted) | $0.52 +13.0% | $0.46 -29.2% | $0.65 -50.8% | $1.32 +51.7% | $0.87 -22.3% | $1.12 |
| Total Assets | $790.7M +9.7% | $720.8M -7.3% | $777.5M -1.0% | $785.0M +8.6% | $722.6M +4.3% | $692.6M |
| Operating Cash Flow | $43.5M +632.6% | $-8.2M -122.0% | $37.1M -82.9% | $217.2M +132.1% | $93.6M +16.9% | $80.0M |
AI Insight: HCSG Financial Trends
HCSG revenue plateaued near $464–467M over the past three quarters while net income swings remain volatile, masking an otherwise steady operating cash recovery.
• Revenue grew steadily from $426M in Q2 2024 to $467M in Q4 2025, but stalled — dipping to $463M in Q1 2026.
• Operating cash flow surged to $71M in Q3 2025, the highest in the period, before retreating to $17M in Q4 2025 and rebounding to $44M in Q1 2026.
• Net income swung from -$32M in Q2 2025 to $43M in Q3 2025 — a $75M quarter-over-quarter reversal — raising earnings quality concerns.
• Equity declined from $514M in Q1 2025 to $477M in Q2 2025 before recovering to $514M in Q1 2026, reflecting the net income volatility.
⚠ The -$32M net income spike in Q2 2025 warrants scrutiny — if non-recurring, fine; if structural, revenue growth cannot offset it.
⚠ Revenue growth has effectively stalled at ~$463–467M for three consecutive quarters — a potential ceiling that limits earnings expansion.
⚠ Op CF recovery to $44M in Q1 2026 is encouraging; sustained FCF generation above $30M per quarter would signal improving earnings quality.
AI Insight: HCSG Ratio Trends
HCSG has staged a strong profitability recovery, with Q1 2026 operating margin rising to 7.5% and ROIC reaching 26.9%, well above year-ago levels.
• Operating margin swung from -9.1% in Q2 2025 to 12.3% in Q3 2025, then settled at 7.5% in Q1 2026 — a decisive recovery.
• ROIC expanded from -35.1% in Q2 2025 to 46.2% in Q3 2025 and 26.9% in Q1 2026, signaling restored capital efficiency.
• ROE and ROA follow the same pattern: ROE reached 20.3% and ROA 12.8% in Q1 2026, versus -27.1% and -16.1% just two quarters prior.
⚠ Results are highly volatile quarter-to-quarter — Q2 2025's deep loss followed Q1 2025 profitability, raising questions about earnings quality.
⚠ TTM operating margin of 4.2% trails the latest Q1 2026 quarterly rate of 7.5%, suggesting prior-period drags still weigh on full-year results.
⚠ D/E data is entirely absent across all periods, leaving leverage and balance-sheet risk unassessable.
Get alerted when HCSG's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for HEALTHCARE SERVICES GROUP INC including:
Top Institutional Holders of HCSG
BlackRock, Inc.
$212.6M11,458,596 shVANGUARD PORTFOLIO MANAGEMENT LLC
$89.9M4,846,133 shVANGUARD CAPITAL MANAGEMENT LLC
$57.9M3,119,545 shSTATE STREET CORP
$52.3M2,819,125 shMACKENZIE FINANCIAL CORP
$49.6M2,672,214 shAMERICAN CENTURY COMPANIES INC
$46.5M2,508,427 shDIMENSIONAL FUND ADVISORS LP
$44.5M2,400,681 shAMERIPRISE FINANCIAL INC
$40.2M2,165,744 shROYCE & ASSOCIATES LP
$39.8M2,143,237 shGEODE CAPITAL MANAGEMENT, LLC
$37.9M2,044,596 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $212.6M | 11,458,596 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $89.9M | 4,846,133 |
| VANGUARD CAPITAL MANAGEMENT LLC | $57.9M | 3,119,545 |
| STATE STREET CORP | $52.3M | 2,819,125 |
| MACKENZIE FINANCIAL CORP | $49.6M | 2,672,214 |
| AMERICAN CENTURY COMPANIES INC | $46.5M | 2,508,427 |
| DIMENSIONAL FUND ADVISORS LP | $44.5M | 2,400,681 |
| AMERIPRISE FINANCIAL INC | $40.2M | 2,165,744 |
| ROYCE & ASSOCIATES LP | $39.8M | 2,143,237 |
| GEODE CAPITAL MANAGEMENT, LLC | $37.9M | 2,044,596 |
More Healthcare Companies
View all Healthcare →Put HCSG on your watchlist
Track score changes the day HEALTHCARE SERVICES GROUP INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is HCSG a good stock to buy?
13F Pro's AI-powered analysis of HEALTHCARE SERVICES GROUP INC (HCSG) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HCSG are available on the HCSG stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own HCSG?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HCSG. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of HEALTHCARE SERVICES GROUP INC's investment landscape.